Home › Funds › Alta Partners Management Company, L.P. › VIR

Alta Partners Management Company, L.P. position in VIR

VIR BIOTECHNOLOGY INC · Health Care

Alta Partners Management Company, L.P. reported holding 509,917 shares of VIR (VIR BIOTECHNOLOGY INC) in its Q2 2026 13F filing — a position valued at US$5.2M, representing 4.08% of its reported portfolio and ranking #2 among its reported holdings. Alta Partners Management Company, L.P. has disclosed VIR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)509.92K sh
Reported value held$5.20M
Portfolio Weight4.08%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Alta Partners Management Company, L.P.'s VIR position evolved

Alta Partners Management Company, L.P. first disclosed a stake in VIR in Q4 2024 at 489,485 shares (US$3.6M). The position peaked in Q2 2026 at 509,917 shares, worth US$5.2M. Across 7 filings, Alta Partners Management Company, L.P. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 509,917 shares valued at US$5.2M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 489.49K $3.59M New
Q1 2025 501.92K $3.25M Add
Q2 2025 509.92K $2.57M Add
Q3 2025 509.92K $2.91M Hold
Q4 2025 509.92K $3.07M Hold
Q1 2026 509.92K $4.57M Hold
Q2 2026 509.92K $5.20M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VIR and 13F data

VIR (VIR BIOTECHNOLOGY INC) is a Health Care company. 49 other funds we track also report a position in VIR — the largest reported positions include ARCH Venture Management, LLC (US$129.4M), SB INVESTMENT ADVISERS (UK) LTD (US$111.6M), GSK plc (US$87.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VIR

All VIR fund holders →

FAQ

How long has Alta Partners Management Company, L.P. held VIR?

Alta Partners Management Company, L.P. has disclosed VIR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Alta Partners Management Company, L.P.'s current position in VIR?

As of Q2 2026, Alta Partners Management Company, L.P. holds 509.92K shares of VIR (VIR BIOTECHNOLOGY INC), valued at $5.20M, representing 4.08% of its reported portfolio and ranking #2.

Has Alta Partners Management Company, L.P. been buying or selling VIR?

In the latest 13F filing (Q2 2026), Alta Partners Management Company, L.P. held unchanged its position in VIR. The position peaked in Q2 2026 at 509.92K shares.

Which other funds hold VIR?

Other major institutional holders of VIR include ARCH Venture Management, LLC, SB INVESTMENT ADVISERS (UK) LTD, GSK plc, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.